ITXASO
GONZALEZ ORTEGA
Ikertzaileren 2011-2018 tartean
Hospital Ramón y Cajal
Madrid, EspañaHospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2023
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden
Schizophrenia Research, Vol. 248, pp. 331-340
-
The network structure of cognitive deficits in first episode psychosis patients
Schizophrenia Research, Vol. 244, pp. 46-54
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
2020
-
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710
2018
-
Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables
Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
2017
-
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study
European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359